EDITORS
GUNDA GEORG
University of Minnesota 612-624-6184
[email protected] University of Michigan 734-615-2399
[email protected] ASSOCIATE EDITORS Jürgen Bajorath University of Bonn
[email protected] Brian S. J. Blagg University of Kansas
[email protected] Maria Laura Bolognesi University of Bologna
[email protected] Stuart Conway University of Oxford
[email protected] Mark Cushman Purdue University
[email protected] SHAOMENG WANG
DRUG ANNOTATIONS EDITORS Carlos Garcia-Echeverria Sanofi 612-624-6184
[email protected] Richard A. Glennon Virginia Commonwealth University
[email protected] Jeff Zablocki Gilead Sciences Inc. 612-624-6184
[email protected] Carrie Haskell-Luevano University of Minnesota
[email protected] Ulrike Holzgrabe University of Würzburg
[email protected] PERSPECTIVES EDITOR
William J. Greenlee MedChem Discovery Consulting, LLC 908-463-5332 greenlee@ jmedchem.acs.org
Hualiang Jiang Shanghai Institute of Materia Medica
[email protected] EDITOR EMERITUS Philip S. Portoghese University of Minnesota
MANAGING EDITOR Lorraine Clark
[email protected] EDITORIAL ADVISORY BOARD Courtney C. Aldrich University of Minnesota, USA Jane Aldrich University of Florida, USA Karl-Heinz Altmann ETH Zurich, Switzerland Jonathan Baell Monash University, Australia Joel C. Barrish Achillion Pharmaceuticals, Inc., USA Julian Blagg Institute of Cancer Research, UK Giuseppe Campiani University of Siena, Italy Carsten Carlberg University of Eastern Finland, Finland Heather A. Carlson University of Michigan, USA Ji-Wang Chern National Taiwan University, Taiwan Kelly Chibale University of Cape Town, South Africa Miles Congreve Heptares Therapeutics, UK William Denny University of Auckland, New Zealand Ke Ding Guangzhou Institute of Biomedicine & Health, Chinese Academy of Sciences, China Stevan Djuric AbbVie, USA Jason E. Gestwicki University of California, San Francisco, USA Michael K. Gilson University of California, San Diego, USA R. Kiplin Guy University of Kentucky, USA Rolf W. Hartmann Saarland University, Germany Ajay Jain University of California, San Francisco, USA
Lak Shin Jeong Seoul National University, Republic of Korea Lucienne Juillerat-Jeanneret CHUV-University of Lausanne, Switzerland Alan P. Kozikowski University of Illinois, USA Stefan A. Laufer University of Tübingen, Germany Jeewoo Lee Seoul National University, Republic of Korea Jing-Ping Liou Taipei Medical University, Taiwan Hong Liu Shanghai Institute of Materia Medica, China Hans Matter Sanofi-Aventis Pharma Deutschland GmbH, Germany Shelli R. McAlpine University of New South Wales, Australia Christopher R. McCurdy University of Mississippi, USA Nicholas Meanwell Bristol-Myers Squibb, USA Vincent Mikol Sanofi-Aventis, France Carlos Alberto Montanari University of Sao Paulo, Brazil Susan L. Mooberry University of Texas Health Science Center, USA Nouri Neamati University of Michigan, USA Ettore Novellino University of Naples, Italy Dafydd R. Owen Pfizer, USA Juan Bautista Rodriguez University of Buenos Aires, Argentina Raffaella Rossin Tagworks Pharmaceuticals, Netherlands Joachim Rudolph Genentech, USA
Chunquan Sheng Second Military Medical University, China Robert P. Sheridan Merck Research Laboratories, USA Satoshi Shuto Hokkaido University, Japan Romano Silvestri Sapienza University of Rome, Italy Martin Stahl F. Hoffman-La Roche Ltd., Switzerland Takayoshi Suzuki Kyoto Prefectural University of Medicine, Japan Guozhi Tang Ascentage Pharma, China Jonathan L. Vennerstrom University of Nebraska Medical Center, USA Ram A. Vishwakarma Indian Institute of Integrative Medicine, India W. Patrick Walters Vertex Pharmaceuticals, USA Ruth R. Wexler Bristol-Myers Squibb, USA Patrick M. Woster Medical University of South Carolina, USA Qidong You China Pharmaceutical University, China Ao Zhang Shanghai Institute of Materia Medica, China Weiliang Zhu Shanghai Institute of Materia Medica, China Ex officio Renate Griffith University of New South Wales, Australia Asian Federation of Medicinal Chemistry Ex officio Augustyns Koen University of Antwerp, Belgium European Federation of Medicinal Chemistry Ex officio Andrew W. Stamford Merck Research Laboratories, USA ACS Division of Medicinal Chemistry Ex officio John E. Macor Bristol-Myers Squibb, USA ACS Division of Medicinal Chemistry
